Seynaeve C - Search Results

1

[Chemotherapy in metastasized breast carcinoma].

Bontenbal M, de Wit R, Klijn JG, Seynaeve C. Bontenbal M, et al. Among authors: seynaeve c. Ned Tijdschr Geneeskd. 1998 Jul 25;142(30):1709-13. Ned Tijdschr Geneeskd. 1998. PMID: 9763866 Review. Dutch.

2

Novel endocrine therapies in breast cancer.

Klijn JG, Setyono-Han B, Bontenbal M, Seynaeve C, Foekens J. Klijn JG, et al. Among authors: seynaeve c. Acta Oncol. 1996;35 Suppl 5:30-7. doi: 10.3109/02841869609083965. Acta Oncol. 1996. PMID: 9142962 Review.

3

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane.

Smorenburg CH, Bontenbal M, Seynaeve C, van Zuylen C, de Heus G, Verweij J, de Wit R. Smorenburg CH, et al. Among authors: seynaeve c. Breast Cancer Res Treat. 2001 Mar;66(1):83-7. doi: 10.1023/a:1010679127390. Breast Cancer Res Treat. 2001. PMID: 11368414 Clinical Trial.

4

[Preventive surgical prcedures for inherited risk of breast cancer].

Menke-Pluymers MB, Seynaeve C, van Geel AN, Klijn JG, Meijers-Heijboer EJ, Eggermont AM. Menke-Pluymers MB, et al. Among authors: seynaeve c. Ned Tijdschr Geneeskd. 2005 Nov 26;149(48):2663-7. Ned Tijdschr Geneeskd. 2005. PMID: 16358615 Review. Dutch.

5

Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.

de Wit R, Verweij J, Bontenbal M, Kruit WH, Seynaeve C, Schmitz PI, Stoter G. de Wit R, et al. Among authors: seynaeve c. J Natl Cancer Inst. 1996 Oct 2;88(19):1393-8. doi: 10.1093/jnci/88.19.1393. J Natl Cancer Inst. 1996. PMID: 8827017 Clinical Trial.

6

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

Verhoog LC, Brekelmans CT, Seynaeve C, Dahmen G, van Geel AN, Bartels CC, Tilanus-Linthorst MM, Wagner A, Devilee P, Halley DJ, van den Ouweland AM, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. Among authors: seynaeve c. J Clin Oncol. 1999 Nov;17(11):3396-402. doi: 10.1200/JCO.1999.17.11.3396. J Clin Oncol. 1999. PMID: 10550133

7

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer.

Verhoog LC, Brekelmans CT, Seynaeve C, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. Among authors: seynaeve c. Br J Cancer. 2000 Aug;83(3):384-6. doi: 10.1054/bjoc.2000.1239. Br J Cancer. 2000. PMID: 10917555 Free PMC article.

8

Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.

Verhoog LC, Berns EM, Brekelmans CT, Seynaeve C, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. Among authors: seynaeve c. J Clin Oncol. 2000 Nov 1;18(21 Suppl):119S-24S. J Clin Oncol. 2000. PMID: 11060339 Review.

9

Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients.

Smorenburg CH, Seynaeve C, Bontenbal M, Planting AS, Sindermann H, Verweij J. Smorenburg CH, et al. Among authors: seynaeve c. Anticancer Drugs. 2000 Nov;11(10):825-8. doi: 10.1097/00001813-200011000-00006. Anticancer Drugs. 2000. PMID: 11142690 Clinical Trial.

10

Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer.

Smorenburg CH, ten Tije AJ, Verweij J, Bontenbal M, Mross K, van Zomeren DM, Seynaeve C, Sparreboom A. Smorenburg CH, et al. Among authors: seynaeve c. Eur J Cancer. 2003 Jan;39(2):196-202. doi: 10.1016/s0959-8049(02)00611-1. Eur J Cancer. 2003. PMID: 12509952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters